- 1. 2B1
- [A monoclonal antibody with potential antineoplastic activity. Specific for both the immunoglobulin G (IgG) receptor CD16 and c-erbB-2, bispecific antibody 2B1 may enhance cellular immune responses against c-erbB-2-positive cells, resulting in increased tumor cell lysis. (NCI04) ( NCI )] (UMLS (NCI) C0338223) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 8. BB-2516/CTX/DOX
- (UMLS (NCI) C0677742) =Therapeutic or Preventive Procedure ;
|
- 2. B01, B02
- (UMLS (HL7) C1549851) =Intellectual Product =Message structure;
| - 9. BB-2516/TMX
- (UMLS (NCI) C0677738) =Therapeutic or Preventive Procedure ;
|
- 3. B04, B05, B06
- (UMLS (HL7) C1549853) =Intellectual Product =Message structure;
| - 10. BBB
- [a physical barrier and a system of cellular transport mechanisms which maintain homeostasis in the brain by restricting the entrance of potentially harmful chemicals from the blood and by allowing the entrance of essential nutrients. ( CSP )] (UMLS (CSP) C0005854) =Body Part, Organ, or Organ Component ;
=brain;
cerebrovascular system |
- 4. B4B Protein
- [epithelial membrane protein-1. Thought to be involved in cell-cell interactions and the control of cell proliferation. Found to be highly expressed in brain tumor cells but not in normal brain. ( NCI )] (UMLS (NCI) C0384479) =Amino Acid, Peptide, or Protein; Receptor ;
| - 11. BBBD VIA INFUSION
- [ ] (UMLS (ICD9CM) C1955622) Disruption of blood brain barrier via infusion [BBBD];
=Therapeutic or Preventive Procedure |
- 5. BB 2516
- (UMLS (NCI) C0663405) =Organic Chemical; Pharmacologic Substance ;
| - 12. BBM 2478A
- (UMLS (NCI) C0105343) =Organic Chemical; Antibiotic ;
|
- 6. BB-10901
- [An immunoconjugate of a humanized murine monoclonal antibody (huN-901) and DMI, a semi-synthetic derivative of the plant-derived ansa macrolide maytansine. The antibody moiety of BB-10901 selectively attaches to CD56 antigen, a neural cell adhesion molecule (NCAM)) expressed on the surface of cells of small cell lung cancer (SCLC) and other neuroendocrine (NE) tumors. Thus, the DMI conjugate is targeted specifically to CD56-expressing tumor cells, where it inhibits tubulin polymerization and assembly, resulting in inhibition of mitosis and cell cycle arrest in the S phase. (NCI04) ( NCI )] (UMLS (NCI) C1328708) =Pharmacologic Substance; Immunologic Factor ;
| - 13. BBR 3464
- [A substance that is being studied as an anticancer drug. It belongs to the family of platinum-based drugs. ( NCI )] (UMLS (NCI) C0756613) =Organic Chemical; Pharmacologic Substance
|
- 7. BB-2516/5-FU
- (UMLS (NCI) C0393045) =Therapeutic or Preventive Procedure
| |
home
